Medicine & TechnologyThe Food and Drug Administration earlier today announced the approval of the Aduhelm Alzheimer's Drug, a high-profile medication for the disease.
Over 1.1 million Medicare patients could die in the next ten years due to the high cost of drugs, according to a new study by the West Health Policy Center.